Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Mabs
|
June 8, 2019
Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunity
Kristina Ellwanger, Uwe Reusch, Ivica Fucek, et al.
Mabs
|
March 28, 2014
A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30+ tumor cells
Uwe Reusch, Carmen Burkhardt, Ivica Fucek, et al.
Scientific Reports
|
September 20, 2013
Anti-LRP/LR specific antibody IgG1-iS18 and knock-down of LRP/LR by shRNAs rescue cells from Aβ42 induced cytotoxicity
Bianca Da Costa Dias, Katarina Jovanovic, Danielle Gonsalves, et al.
Protein Engineering, Design & Selection : PEDS
|
October 6, 2017
Trispecific antibodies for CD16A-directed NK cell engagement and dual-targeting of tumor cells
Thorsten Gantke, Michael Weichel, Carmen Herbrecht, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 6, 2013
Rescue of impaired NK cell activity in hodgkin lymphoma with bispecific antibodies in vitro and in patients
Katrin S Reiners, Jörg Kessler, Maike Sauer, et al.
Molecular Immunology
|
June 20, 2007
Single chain Fv antibodies directed against the 37 kDa/67 kDa laminin receptor as therapeutic tools in prion diseases
Chantal Zuber, Stefan Knackmuss, Clémence Rey, et al.
The Journal of General Virology
|
July 18, 2008
Delivery of single-chain antibodies (scFvs) directed against the 37/67 kDa laminin receptor into mice via recombinant adeno-associated viral vectors for prion disease gene therapy
Chantal Zuber, Gerda Mitteregger, Natascha Schuhmann, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 16, 2019
Functionally Defective T Cells After Chemotherapy of B-Cell Malignancies Can Be Activated by the Tetravalent Bispecific CD19/CD3 Antibody AFM11
Johannes Duell, Dragana S Lukic, Margarete Karg, et al.
Journal of Alzheimer'S Disease : JAD
|
October 21, 2015
LRP/LR Antibody Mediated Rescuing of Amyloid-β-Induced Cytotoxicity is Dependent on PrPc in Alzheimer's Disease
Emma C Pinnock, Katarina Jovanovic, Maxine G Pinto, et al.
Plos One
|
November 7, 2015
Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity
Kerrilyn Naidoo, Sibusiso T Malindisa, Tyrone C Otgaar, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Mabs
|
June 8, 2019
Redirected optimized cell killing (ROCK®): A highly versatile multispecific fit-for-purpose antibody platform for engaging innate immunity
Kristina Ellwanger, Uwe Reusch, Ivica Fucek, et al.
Mabs
|
March 28, 2014
A novel tetravalent bispecific TandAb (CD30/CD16A) efficiently recruits NK cells for the lysis of CD30+ tumor cells
Uwe Reusch, Carmen Burkhardt, Ivica Fucek, et al.
Scientific Reports
|
September 20, 2013
Anti-LRP/LR specific antibody IgG1-iS18 and knock-down of LRP/LR by shRNAs rescue cells from Aβ42 induced cytotoxicity
Bianca Da Costa Dias, Katarina Jovanovic, Danielle Gonsalves, et al.
Protein Engineering, Design & Selection : PEDS
|
October 6, 2017
Trispecific antibodies for CD16A-directed NK cell engagement and dual-targeting of tumor cells
Thorsten Gantke, Michael Weichel, Carmen Herbrecht, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
March 6, 2013
Rescue of impaired NK cell activity in hodgkin lymphoma with bispecific antibodies in vitro and in patients
Katrin S Reiners, Jörg Kessler, Maike Sauer, et al.
Molecular Immunology
|
June 20, 2007
Single chain Fv antibodies directed against the 37 kDa/67 kDa laminin receptor as therapeutic tools in prion diseases
Chantal Zuber, Stefan Knackmuss, Clémence Rey, et al.
The Journal of General Virology
|
July 18, 2008
Delivery of single-chain antibodies (scFvs) directed against the 37/67 kDa laminin receptor into mice via recombinant adeno-associated viral vectors for prion disease gene therapy
Chantal Zuber, Gerda Mitteregger, Natascha Schuhmann, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
May 16, 2019
Functionally Defective T Cells After Chemotherapy of B-Cell Malignancies Can Be Activated by the Tetravalent Bispecific CD19/CD3 Antibody AFM11
Johannes Duell, Dragana S Lukic, Margarete Karg, et al.
Journal of Alzheimer'S Disease : JAD
|
October 21, 2015
LRP/LR Antibody Mediated Rescuing of Amyloid-β-Induced Cytotoxicity is Dependent on PrPc in Alzheimer's Disease
Emma C Pinnock, Katarina Jovanovic, Maxine G Pinto, et al.
Plos One
|
November 7, 2015
Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity
Kerrilyn Naidoo, Sibusiso T Malindisa, Tyrone C Otgaar, et al.
Page
of 4